Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, Abubakar M, Andrulis IL, Anton-Culver H, Beckmann MW, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, Briceno I, Burwinkel B, Camp NJ, Castelao JE, Choi JY, Clarke CL, Couch FJ, Cox A, Cross SS, Czene Ket al.(2022) Incorporating progesterone receptor expression into the PREDICT breast prognostic model Eur J Cancer, 173, 178-193(in press) DOI 10.1016/j.ejca.2022.06.011, PubMed 35933885
Pedersen CA, Cao MD, Fleischer T, Rye MB, Knappskog S, Eikesdal HP, Lønning PE, Tost J, Kristensen VN, Tessem MB, Giskeødegård GF, Bathen TF(2022) DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival Breast Cancer Res, 24(1), 43 DOI 10.1186/s13058-022-01537-9, PubMed 35751095
Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, González-Neira A, Heijl SM, Adank MA, Ahearn TU, Andrulis IL, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, Bolla MK, Bremer M, Briceno I, Camp NJ, Campbell A, Castelao JE, Chang-Claude J, Chanock SJet al.(2022) Breast cancer risks associated with missense variants in breast cancer susceptibility genes Genome Med, 14(1), 51 DOI 10.1186/s13073-022-01052-8, PubMed 35585550